In-Home Specimen Collection Allows Clinical Trials to Continue During the Coronavirus Crisis
Brian Neman, MHA
Acquiring samples from patients within the comfort of their own homes could help clinical trials move forward during the pandemic
Brian Neman, MHA
Brian Neman serves as the co-founder and CEO of Sanguine Biosciences. Brian focuses on all items relating to commercialization and relationships with researchers. He is an adjunct professor of digital health at the University of Southern California (USC) and co-founded Sanguine in 2010 out of his graduate program in health care administration at USC. He is also on the boards and committees of various organizations including HD Care and BIOCOM Big Data Committee.